|
HbA1C
|
|
|
| IDF |
<7% (53 mmol/L) |
IDF 2017[@15200] |
| WHO |
<6.5% (48 mmol/L) |
WHO 2007[@15201] |
| NICE |
<6.5% (48 mmol/L) |
NICE 2015[@15202] |
| ADA |
<7% (53 mmol/L) |
ADA 2016[@15203] |
|
Blood Pressure
|
|
|
| IDF |
Systolic: 130-140 mmHg |
IDF 2017[@15200] |
| Diastolic: 80 mmHg |
|
| WHO |
130/80 mmHg |
WHO 2007[@15201] |
| NICE |
<140/80 mmHg |
NICE 2009[@15204] |
| ADA |
<140/90 mmHg |
De Boer et al. 2017[@15205] |
|
Cholesterol
|
|
|
| IDF |
LDL cholesterol <2.6 mmol/L |
IDF 2017[@15200] |
| WHO |
Total cholesterol <4.0 mmol/L (152 mg/dl) |
WHO 2007[@15201] |
| LDL cholesterol <2.0 mmol/L (77mg/dl) |
|
| NICE |
LDL cholesterol <2.0mmol/L |
NICE 2012[@15206] |
| HDL cholesterol <1.4 mmol/L |
|
| Total cholesterol <4.0 mmol/L |
|
| ADA |
LDL cholesterol <2.6mmol/L (100mg/dl) |
Eldor and Raz 2009[@15207] |